mitoxantrone has been researched along with Ataxia Telangiectasia Syndrome in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, PJ | 1 |
| Blunt, NJ | 1 |
| Desnoyers, R | 1 |
| Giles, Y | 1 |
| Patterson, LH | 1 |
1 other study available for mitoxantrone and Ataxia Telangiectasia Syndrome
| Article | Year |
|---|---|
DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides.
Topics: Anthraquinones; Antineoplastic Agents; Ataxia Telangiectasia; Cell Line; Cell Line, Transformed; Cel | 1997 |